These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20865648)

  • 1. Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men.
    Hong JW; Kim JY; Kim YE; Lee EJ
    Horm Metab Res; 2011 Jan; 43(1):48-54. PubMed ID: 20865648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients.
    Yuan XX; Zhu HJ; Pan H; Chen S; Liu ZY; Li Y; Wang LJ; Lu L; Yang HB; Gong FY
    World J Gastroenterol; 2019 Apr; 25(14):1741-1752. PubMed ID: 31011258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy.
    Nishizawa H; Iguchi G; Murawaki A; Fukuoka H; Hayashi Y; Kaji H; Yamamoto M; Suda K; Takahashi M; Seo Y; Yano Y; Kitazawa R; Kitazawa S; Koga M; Okimura Y; Chihara K; Takahashi Y
    Eur J Endocrinol; 2012 Jul; 167(1):67-74. PubMed ID: 22535644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty liver disease and metabolic syndrome in hypopituitary patients.
    Nyenwe EA; Williamson-Baddorf S; Waters B; Wan JY; Solomon SS
    Am J Med Sci; 2009 Sep; 338(3):190-5. PubMed ID: 19745609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
    Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
    Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
    Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency.
    Kang SJ; Kwon A; Jung MK; Chae HW; Kim S; Koh H; Shin HJ; Kim HS
    Endocr Pract; 2021 Nov; 27(11):1149-1155. PubMed ID: 34126247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I.
    Arturi F; Succurro E; Procopio C; Pedace E; Mannino GC; Lugarà M; Procopio T; Andreozzi F; Sciacqua A; Hribal ML; Perticone F; Sesti G
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1640-4. PubMed ID: 21816784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory cardiovascular risk markers in women with hypopituitarism.
    Sesmilo G; Miller KK; Hayden D; Klibanski A
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5774-81. PubMed ID: 11739438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the prevalence of metabolic syndrome and its components in hypopituitary patients: comparison with an age- and sex-matched nationwide control group.
    Khang AR; Ku EJ; Kim YA; Roh E; Bae JH; Oh TJ; Kim SW; Shin CS; Kim SY; Kim JH
    Pituitary; 2016 Dec; 19(6):573-581. PubMed ID: 27577046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
    Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels.
    Fusco A; Miele L; D'Uonnolo A; Forgione A; Riccardi L; Cefalo C; Barini A; Bianchi A; Giampietro A; Cimino V; Landolfi R; Grieco A; De Marinis L
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):531-6. PubMed ID: 22077984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study.
    Christ ER; Cummings MH; Stolinski M; Jackson N; Lumb PJ; Wierzbicki AS; Sönksen PH; Russell-Jones DL; Umpleby AM
    Eur J Endocrinol; 2006 Mar; 154(3):459-66. PubMed ID: 16498060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
    Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in overweight children and adolescents.
    Sagi R; Reif S; Neuman G; Webb M; Phillip M; Shalitin S
    Acta Paediatr; 2007 Aug; 96(8):1209-13. PubMed ID: 17655622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects.
    Kim NH; Kim JH; Kim YJ; Yoo HJ; Kim HY; Seo JA; Kim NH; Choi KM; Baik SH; Choi DS; Kim SG
    Liver Int; 2014 Apr; 34(4):604-11. PubMed ID: 24382309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.